These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21170065)

  • 1. Insurance coverage for erectile dysfunction drugs.
    Hornbrook MC; Holup J
    Clin Pharmacol Ther; 2011 Jan; 89(1):19-21. PubMed ID: 21170065
    [No Abstract]   [Full Text] [Related]  

  • 2. Where cost, medical necessity, and morality meet: should US government insurance programs pay for erectile dysfunction drugs?
    Polinski JM; Kesselheim AS
    Clin Pharmacol Ther; 2011 Jan; 89(1):17-9. PubMed ID: 21170064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Treatment of erectile dysfunction].
    Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2010 Sep; 39(5):385-90. PubMed ID: 20818688
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of erectile dysfunction course on its progress and efficacy of treatment with phosphodiesterase type 5 inhibitors.
    Liu DF; Jiang H; Hong K; Zhao LM; Tang WH; Ma LL
    Chin Med J (Engl); 2010 Nov; 123(22):3258-61. PubMed ID: 21163126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coverage of erectile dysfunction therapies within the managed care community.
    Kenney JT
    Am J Manag Care; 2000 Aug; 6(12 Suppl):S644-6. PubMed ID: 11183418
    [No Abstract]   [Full Text] [Related]  

  • 6. ED drugs covered, but managed care unmoved.
    Manag Care; 2005 Mar; 14(3):64. PubMed ID: 15825613
    [No Abstract]   [Full Text] [Related]  

  • 7. Stats & facts. The rapidly growing market of erectile dysfunction.
    Manag Care Interface; 1998 Jul; 11(7):44-5. PubMed ID: 10181567
    [No Abstract]   [Full Text] [Related]  

  • 8. [ Editorial. Pharmazie in unserer Zeit 5/2010].
    Dingermann T; Schubert-Zsilavecz M
    Pharm Unserer Zeit; 2010 Sep; 39(5):331. PubMed ID: 20818677
    [No Abstract]   [Full Text] [Related]  

  • 9. Avanafil (Stendra)--another PDE5 inhibitor for erectile dysfunction.
    Med Lett Drugs Ther; 2014 May; 56(1442):37-8. PubMed ID: 24818838
    [No Abstract]   [Full Text] [Related]  

  • 10. Complementary medicine and erectile dysfunction: will you accept the charges?
    Jackson G
    Int J Clin Pract; 2011 Mar; 65(3):231. PubMed ID: 21314857
    [No Abstract]   [Full Text] [Related]  

  • 11. Sexually transmitted infection in HIV-positive men with erectile dysfunction using phosphodiesterase-5 inhibitors.
    McCarty EJ; Quinn K; Dinsmore WW
    Sex Transm Infect; 2011 Oct; 87(6):455. PubMed ID: 21764891
    [No Abstract]   [Full Text] [Related]  

  • 12. [Nitrates and PDE5 inhibitors: pharmaceutical care].
    Ude M; Ude C; Leuner K
    Pharm Unserer Zeit; 2010 Sep; 39(5):397-404. PubMed ID: 20818690
    [No Abstract]   [Full Text] [Related]  

  • 13. Which drug for erectile dysfunction? There are some potentially helpful differences between these medications, but price can limit your choices.
    Harv Mens Health Watch; 2014 Jun; 18(11):6-7. PubMed ID: 25029709
    [No Abstract]   [Full Text] [Related]  

  • 14. [Price reduction of PDE5 inhibitor motivated].
    Ericsson T; Brembeck P
    Lakartidningen; 2011 Aug 10-23; 108(32-33):1505. PubMed ID: 21922947
    [No Abstract]   [Full Text] [Related]  

  • 15. An Analysis of a Commercial Database on the Use of Erectile Dysfunction Treatments for Men With Employer-Sponsored Health Insurance.
    Burnett AL; Rojanasarot S; Amorosi SL
    Urology; 2021 Mar; 149():140-145. PubMed ID: 33309705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managed care and sexual dysfunction. Based on a presentation by William Parham, MD.
    Am J Manag Care; 1999 Jan; 5(1 Suppl):S23-7; discussion S28-30. PubMed ID: 10345973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of erectile dysfunction after radical prostatectomy].
    Radnaev LG; Govorov AV; Pushkar' DIu
    Urologiia; 2010; (4):75-9. PubMed ID: 20967987
    [No Abstract]   [Full Text] [Related]  

  • 18. Access to innovative treatment of erectile dysfunction: clinical, economic, and quality-of-life considerations.
    Fendrick AM
    Am J Manag Care; 2000 Aug; 6(12 Suppl):S632-8. PubMed ID: 11183415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health economics and sexual dysfunction. Based on a presentation by Cyril F. Chang, PhD.
    Am J Manag Care; 1999 Jan; 5(1 Suppl):S15-8; discussion S19-22. PubMed ID: 10345972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescribing of phosphodiesterase-5 inhibitors among psychiatrists.
    Balon R; Morreale MK; Segraves RT
    J Sex Marital Ther; 2014; 40(3):165-9. PubMed ID: 24308822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.